🇺🇸 FDA
Patent

US 7064112

Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

granted A61KA61K31/00A61K31/52

Quick answer

US patent 7064112 (Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist) held by CAN-FITE BIOPHARMA LTD. expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAN-FITE BIOPHARMA LTD.
Grant date
Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K31/00, A61K31/52, A61K31/70, A61K31/706